These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 15100679

  • 21. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 22. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
    Langley JM, Aoki F, Ward BJ, McGeer A, Angel JB, Stiver G, Gorfinkel I, Shu D, White L, Lasko B, Dzongowski P, Papp K, Alexander M, Boivin G, Fries L.
    Vaccine; 2011 Feb 24; 29(10):1921-8. PubMed ID: 21219987
    [Abstract] [Full Text] [Related]

  • 23. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul 24; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 24. Effective immunization against influenza in pediatric renal transplant recipients.
    Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ.
    Clin Transplant; 1996 Dec 24; 10(6 Pt 1):556-60. PubMed ID: 8996778
    [Abstract] [Full Text] [Related]

  • 25. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP.
    Clin Infect Dis; 2009 Apr 15; 48(8):1087-95. PubMed ID: 19281330
    [Abstract] [Full Text] [Related]

  • 26. Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors.
    Bektas O, Karadeniz C, Oguz A, Berberoglu S, Yilmaz N, Citak C.
    Pediatr Blood Cancer; 2007 Dec 15; 49(7):914-7. PubMed ID: 17262793
    [Abstract] [Full Text] [Related]

  • 27. Antibody responses after dose-sparing intradermal influenza vaccination.
    Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P.
    Vaccine; 2007 Jan 08; 25(4):659-63. PubMed ID: 17011678
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
    Scharpé J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P.
    Am J Kidney Dis; 2009 Jul 08; 54(1):77-85. PubMed ID: 19339089
    [Abstract] [Full Text] [Related]

  • 29. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy.
    Shahgholi E, Ehsani MA, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T.
    Pediatr Blood Cancer; 2010 May 08; 54(5):716-20. PubMed ID: 20205258
    [Abstract] [Full Text] [Related]

  • 30. Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial.
    Halperin SA, Smith B, Nolan C, Shay J, Kralovec J.
    CMAJ; 2003 Jul 22; 169(2):111-7. PubMed ID: 12874157
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD, D153-P504 LAIV Study Group.
    Pediatr Infect Dis J; 2009 May 22; 28(5):365-71. PubMed ID: 19395948
    [Abstract] [Full Text] [Related]

  • 32. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.
    Cooper CL, Davis HL, Morris ML, Efler SM, Krieg AM, Li Y, Laframboise C, Al Adhami MJ, Khaliq Y, Seguin I, Cameron DW.
    Vaccine; 2004 Aug 13; 22(23-24):3136-43. PubMed ID: 15297066
    [Abstract] [Full Text] [Related]

  • 33. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community.
    Praditsuwan R, Assantachai P, Wasi C, Puthavatana P, Kositanont U.
    J Med Assoc Thai; 2005 Feb 13; 88(2):256-64. PubMed ID: 15962680
    [Abstract] [Full Text] [Related]

  • 34. The safety and immunogenicity of influenza vaccine in children with asthma in Mexico.
    Pedroza A, Huerta JG, Garcia Mde L, Rojas A, López-Martínez I, Penagos M, Franco-Paredes C, Deroche C, Mascareñas C.
    Int J Infect Dis; 2009 Jul 13; 13(4):469-75. PubMed ID: 19084453
    [Abstract] [Full Text] [Related]

  • 35. Immune response after influenza vaccination in children with cancer.
    Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T.
    Pediatr Blood Cancer; 2005 Nov 13; 45(6):831-7. PubMed ID: 16007602
    [Abstract] [Full Text] [Related]

  • 36. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM, Minor TE, Inhorn SL, Reed CE, Dick EC.
    Dev Biol Stand; 1976 Nov 13; 33():184-90. PubMed ID: 782967
    [Abstract] [Full Text] [Related]

  • 37. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.
    Bernstein DI, Edwards KM, Dekker CL, Belshe R, Talbot HK, Graham IL, Noah DL, He F, Hill H.
    J Infect Dis; 2008 Mar 01; 197(5):667-75. PubMed ID: 18260764
    [Abstract] [Full Text] [Related]

  • 38. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M.
    J Infect Dis; 2008 Sep 01; 198(5):650-8. PubMed ID: 18652550
    [Abstract] [Full Text] [Related]

  • 39. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.
    Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737
    [Abstract] [Full Text] [Related]

  • 40. Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study.
    Iorio A, Basileo M, Marcucci M, Guercini F, Camilloni B, Paccamiccio E, Vecchioli M, Iorio AM.
    Arch Intern Med; 2010 Apr 12; 170(7):609-16. PubMed ID: 20386004
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.